Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/9682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLima Serrano, Karla Anaisa-
dc.date.accessioned2015-06-05T15:27:00Z-
dc.date.available2015-06-05T15:27:00Z-
dc.date.issued2015-06-05-
dc.identifier.urihttp://hdl.handle.net/10872/9682-
dc.description.abstractPharmaceutical companies have to demonstrate that the products they produce contain exactly the specified load of active chemical necessary to obtain a quality product. Validation is the scientifical process to do that and is an absolute requirement that every company must met, according to Good Manufacturing Practices (GMP) and the United States Pharmacopeial (USP), and must be properly documented, allowing assure that the methods used in the analysis of a product are reliable. Therefore, we want to validate the method of analysis for determining Moxifloxacin tablet which is manufactured in a national laboratory using the technique of high performance liquid chromatography (HPLC).es_VE
dc.language.isoeses_VE
dc.relation.ispartofseries2014;1004-005-
dc.subjectHPLCes_VE
dc.subjectMoxifloxacinaes_VE
dc.subjecttabletases_VE
dc.subjectvalidaciónes_VE
dc.subjectMoxifloxacines_VE
dc.subjecttabletses_VE
dc.subjectvalidationes_VE
dc.titleVALIDACIÓN DE UN MÉTODO POR CROMATOGRAFÍA LÍQUIDA DE ALTA RESOLUCION (HPLC) PARA LOS ENSAYOS DE IDENTIFICACIÓN, POTENCIA, DISOLUCIÓN Y UNIFORMIDAD DE UNIDADES DE DOSIFICACIÓN DE MOXIFLOXACINA EN TABLETAS.es_VE
dc.title.alternativeVALIDATION OF A METHOD FOR HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) FOR TEST OF IDENTIFICATION, ASSAY, DISOLUTION AND UNIFORMITY OF DOSIFICATION OF MOXIFLOXACIN TABLETSes_VE
dc.typeThesises_VE
Appears in Collections:Otras

Files in This Item:
File Description SizeFormat 
T026800011087-0-Karla_Lima_Trabajo_Especial_de_Grado-000.pdf4.02 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.